Pantothenic acid
Vitaped (pantothenic acid) is a small molecule pharmaceutical. Pantothenic acid was first approved as Vitaped on 1993-12-29. It is used to treat vitamin b deficiency in the USA.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area | MeSH |
|---|---|
| nutritional and metabolic diseases | D009750 |
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| bacmin | unapproved drug other | 2014-05-02 |
| centratex | unapproved drug other | 2024-01-31 |
| dialyvite | unapproved drug other | 2026-01-27 |
| dialyvite 5000 | unapproved drug other | 2026-01-27 |
| dialyvite supreme d | unapproved drug other | 2026-01-27 |
| healthy mamabe well rounded | unapproved drug other | 2013-07-09 |
| jba collagen-electrolyte mocktail | unapproved drug other | 2025-03-31 |
| myhephron | unapproved drug other | 2016-08-02 |
| mynephrocaps | unapproved drug other | 2013-12-13 |
| nephplex rx | unapproved drug other | 2021-07-13 |
Show 16 more
Indications
FDA
EMA
Show 18 more
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
314 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Anemia | D000740 | EFO_0004272 | D64.9 | 1 | 1 | — | 3 | 7 | 12 |
| Iron-deficiency anemia | D018798 | — | D50 | — | — | — | 1 | 6 | 7 |
| Tuberculosis | D014376 | EFO_0000774 | A15-A19 | — | 3 | 4 | 1 | — | 6 |
| Chronic kidney failure | D007676 | EFO_0003884 | N18.6 | 1 | 1 | 1 | 1 | 1 | 5 |
| Neoplasms | D009369 | — | C80 | 2 | 1 | — | 1 | 2 | 5 |
| Chronic renal insufficiency | D051436 | — | N18 | 1 | 1 | 1 | 1 | 2 | 5 |
| Iron deficiencies | D000090463 | — | E61.1 | — | — | — | 1 | 4 | 5 |
| Vitamin b 12 deficiency | D014806 | EFO_0000734 | E53.8 | — | — | — | 1 | 3 | 4 |
| Psychological well-being | D000092862 | — | — | — | — | — | 1 | 2 | 3 |
| Atrial fibrillation | D001281 | EFO_0000275 | I48.0 | — | — | 1 | 1 | — | 2 |
Show 30 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Non-small-cell lung carcinoma | D002289 | — | — | 5 | 6 | 7 | — | 1 | 16 |
| Covid-19 | D000086382 | — | U07.1 | 2 | 2 | 7 | — | 3 | 13 |
| Pantothenate kinase-associated neurodegeneration | D006211 | — | G23.0 | — | — | 3 | — | 5 | 8 |
| Lung neoplasms | D008175 | — | C34.90 | 2 | 5 | 2 | — | — | 7 |
| Nerve degeneration | D009410 | — | — | — | — | 3 | — | 4 | 7 |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 2 | 2 | 2 | — | — | 5 |
| Neoplasm metastasis | D009362 | EFO_0009708 | — | 2 | 2 | 1 | — | — | 5 |
| Syndrome | D013577 | — | — | — | — | 1 | — | 4 | 5 |
| Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | — | — | 1 | — | 3 | 4 |
| Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | — | 2 | 2 | — | 2 | 4 |
Show 52 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 3 | 2 | — | — | 8 | 13 |
| Lymphoma | D008223 | — | C85.9 | 5 | 6 | — | — | — | 7 |
| Colorectal neoplasms | D015179 | — | — | 2 | 4 | — | — | 1 | 6 |
| Recurrence | D012008 | — | — | 4 | 3 | — | — | — | 6 |
| Alopecia | D000505 | — | L64 | 1 | 1 | — | — | 5 | 6 |
| Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 1 | 2 | — | — | 1 | 4 |
| Hodgkin disease | D006689 | — | C81 | 3 | 2 | — | — | — | 4 |
| Kidney diseases | D007674 | EFO_0003086 | N08 | 1 | 1 | — | — | 1 | 3 |
| Non-hodgkin lymphoma | D008228 | — | C85.9 | 3 | 1 | — | — | — | 3 |
| T-cell lymphoma | D016399 | — | — | 3 | 2 | — | — | — | 3 |
Show 76 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Inflammation | D007249 | MP_0001845 | — | 1 | — | — | — | 6 | 7 |
| Renal insufficiency | D051437 | — | N19 | 1 | — | — | — | 3 | 4 |
| Myeloid leukemia acute | D015470 | — | C92.0 | 2 | — | — | — | — | 2 |
| Sezary syndrome | D012751 | — | C84.1 | 2 | — | — | — | — | 2 |
| Mycosis fungoides | D009182 | — | C84.0 | 2 | — | — | — | — | 2 |
| T-cell lymphoma cutaneous | D016410 | — | C84.A | 2 | — | — | — | — | 2 |
| Skin neoplasms | D012878 | EFO_0004198 | C44 | 1 | — | — | — | 1 | 2 |
| Acne vulgaris | D000152 | EFO_0003894 | L70 | 1 | — | — | — | 1 | 2 |
| Myelodysplastic syndromes | D009190 | — | D46 | 1 | — | — | — | — | 1 |
| Hematologic neoplasms | D019337 | — | — | 1 | — | — | — | — | 1 |
Show 23 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Vitamin d deficiency | D014808 | EFO_0003762 | E55 | — | — | — | — | 6 | 6 |
| Obesity | D009765 | EFO_0001073 | E66.9 | — | — | — | — | 4 | 4 |
| Autistic disorder | D001321 | EFO_0003758 | F84.0 | — | — | — | — | 4 | 4 |
| Respiratory tract infections | D012141 | — | J06.9 | — | — | — | — | 4 | 4 |
| Infections | D007239 | EFO_0000544 | — | — | — | — | — | 4 | 4 |
| Hypertension | D006973 | EFO_0000537 | I10 | — | — | — | — | 3 | 3 |
| Micronutrients | D018977 | — | — | — | — | — | — | 3 | 3 |
| Diarrhea | D003967 | — | R19.7 | — | — | — | — | 3 | 3 |
| Anxiety disorders | D001008 | EFO_0006788 | F41.1 | — | — | — | — | 3 | 3 |
| Mortality | D009026 | EFO_0004352 | — | — | — | — | — | 2 | 2 |
Show 145 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Pantothenic acid |
| INN | — |
| Description | Pantothenic acid is a member of the class of pantothenic acids that is an amide formed from pantoic acid and beta-alanine. It has a role as a plant metabolite. It is a conjugate acid of a pantothenate. |
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | CC(C)(CO)[C@@H](O)C(=O)NCCC(=O)O |
Identifiers
| PDB | — |
| CAS-ID | 79-83-4 |
| RxCUI | — |
| ChEMBL ID | CHEMBL1594 |
| ChEBI ID | 46905 |
| PubChem CID | 988 |
| DrugBank | DB01783 |
| UNII ID | — |
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 9,999 documents
View more details
Safety
Black-box Warning
Black-box warning for: Healthy mamabe well rounded, Pnv-select
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
757 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use